Related Experiment Video

Updated: Jun 15, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.6K

Psychiatric Comorbidities in Children With Epilepsy

V N V S J Sarat Chandra1, Mahesh Kamate2, Vinayak Koparde1

  • 1Department of Pediatric Neurology, Jawaharlal Nehru Medical College, Belagavi, Karnataka, India.

Indian Pediatrics
|August 28, 2024
PubMed

Insights

Psychiatric comorbidities are frequent in children with epilepsy (CWE), negatively impacting their quality of life (QOL). Early intervention for these conditions can improve QOL in CWE.

Area of Science:

  • Child Neurology
  • Child Psychiatry
  • Quality of Life Research

Background:

  • Epilepsy is a common neurological disorder in children.
  • Children with epilepsy (CWE) often experience psychiatric comorbidities.
  • These comorbidities can significantly affect their overall well-being and quality of life (QOL).

Purpose of the Study:

  • To determine the prevalence of psychiatric comorbidities in children with epilepsy.
  • To assess how these comorbidities impact the QOL of affected children.
  • To evaluate the effectiveness of interventions on QOL.

Main Methods:

  • Children with epilepsy (CWE) and normal IQ were assessed.
  • Psychiatric comorbidities were evaluated using the Revised Child Anxiety and Depression Scale (RCADS) and Strengths and Difficulties Questionnaire (SDQ).
  • Quality of Life in Children with Epilepsy (QOLCE-31) scale measured QOL at baseline and after 3 months of intervention.

Main Results:

  • High prevalence of social phobia (24.4%), major depression (20.0%), generalized anxiety (38.9%), separation anxiety (35.56%), conduct problems (28.89%), and peer problems (13.34%) were observed.
  • Intervention for comorbidities led to noticeable improvements in the QOL of CWE.
  • Specific QOL improvements were linked to the management of identified psychiatric conditions.

Conclusions:

  • Psychiatric comorbidities are highly prevalent in children with epilepsy.
  • These comorbidities are significant contributors to reduced quality of life in this population.
  • Targeted interventions for psychiatric issues can enhance the QOL for children with epilepsy.
Abstract

More Related Videos

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

20.3K
Comparing Eye-tracking Data of Children with High-functioning ASD, Comorbid ADHD, and of a Control Watching Social Videos05:32

Comparing Eye-tracking Data of Children with High-functioning ASD, Comorbid ADHD, and of a Control Watching Social Videos

Published on: December 7, 2018

8.9K

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
309
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
50
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
525
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
81
Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
181
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
351